Pages that link to "Q44124154"
Jump to navigation
Jump to search
The following pages link to Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen (Q44124154):
Displaying 11 items.
- Sequencing of chemotherapy and radiotherapy for early breast cancer (Q24197599) (← links)
- Sequencing of chemotherapy and radiation therapy for early breast cancer (Q24243984) (← links)
- Main controversies in breast cancer (Q27026673) (← links)
- Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer. (Q33370705) (← links)
- Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm? (Q35072438) (← links)
- [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway (Q36381494) (← links)
- Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. (Q40494548) (← links)
- A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma (Q40522396) (← links)
- Antitumor activity of novel N-sulfonylpyrimidine derivatives on the growth of anaplastic mammary carcinoma in vivo (Q46699758) (← links)
- Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (Q54737587) (← links)
- Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: a single centre experience (Q62652596) (← links)